LY293111

A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists.

Sustancia en estudio para el tratamiento del cáncer. Es un tipo de antagonista del receptor B4 de leucotrieno.